PROCESSA PHARMACEUTICALS INC
PCSANASDAQ🏆 #3672 by market capUS Equity
$2.65▼ $0.01 (−0.19%)
Live1h—
24h▼ 0.2%
7d▲ 20.8%
14d▼ 13.6%
30d▲ 20.2%
1y▼ 52.1%
🏦Market Cap
$9M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
32.2%
Moderate
💵FCF Margin
—
⚖️P/S Ratio
90.4x
Expensive
Otter Score
55
Weak
Trading Snapshot
- Day Range
- $2.62 – $2.67
- 52-Week Range
- $1.67 – $14.24
- Volume
- $3.04B
- Avg Volume
- $3.65B
- Shares Outstanding
- 3.4M
- Next Earnings
- Sep 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $80,700
- Last Q Revenue
- $18,909
- P/E Ratio
- —
- P/S Ratio
- 90.4x
- EPS (TTM)
- $-10.90
- Dividend Yield
- —
Why Investors Own PCSA
- ✓High-growth profile — revenue up +46.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 69% gross margin and 14% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$80,700▲ +46.0% YoY
Gross Margin (TTM)
69.1%▲ +2.6% YoY
Operating Income (TTM)
$15,575▲ +46.0% YoY
Free Cash Flow (TTM)
$11,540▲ +46.0% YoY
About PROCESSA PHARMACEUTICALS INC
A company profile for PROCESSA PHARMACEUTICALS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
55/100
Analyst Ratings
ⓘConsensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026
Latest News & Updates
🚀
Barron’s·2h ago
PROCESSA PHARMACEUTICALS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
MarketWatch·5h ago
Analysts lift PCSA price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Bloomberg·1d ago
PROCESSA PHARMACEUTICALS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.